Novel crystalline forms of 2, 3 dimethyl8- (2, 6-dimethylbenzylamino) - N-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.

Details for Australian Patent Application No. 2004299435 (hide)

Owner AstraZeneca AB

Inventors Lilljequist, Lars; Pettersson, Ursula; Nordberg, Peter; Lindkvist, Maria; Sebhatu, Tesfai

Agent Freehills

Pub. Number AU-B-2004299435

PCT Pub. Number WO2005/058895

Priority 0303451-9 18.12.03 SE

Filing date 16 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 17 April 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058895 Priority application(s): WO2005/058895

17 April 2008 Application Accepted

  Published as AU-B-2004299435

14 August 2008 Standard Patent Sealed

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004299438-Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-HT6 receptor-related disorder

2004299433-New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin